BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2438622)

  • 1. Interferon enhances the natural killer cell activity of the retinoblastoma patients to autologous retinoblastoma cells.
    Sasabe T; Kiritoshi A; Ohashi Y; Manabe R
    Ophthalmic Paediatr Genet; 1987 Mar; 8(1):43-6. PubMed ID: 2438622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells kill human retinoblastoma cells.
    Ohashi Y; Sasabe T; Nishida T; Manabe R
    Jpn J Ophthalmol; 1984; 28(4):370-6. PubMed ID: 6085129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human fibroblast interferon on natural killer cell activity: stimulation in vitro and inhibition in vivo.
    Heidemann E; Reichmann U; Wilms K; Treuner J; Niethammer D
    Klin Wochenschr; 1982 Jun; 60(12):625-9. PubMed ID: 6180219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of lysosomotropic amines on spontaneous and interferon enhanced NK and CTL cytolysis.
    Ausiello C; Sorrentino V; Ruggiero V; Rossi GB
    Immunol Lett; 1984; 8(1):11-5. PubMed ID: 6204935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of target cell susceptibility to human natural killer cells by interferon.
    Moore M; White WJ; Potter MR
    Int J Cancer; 1980 May; 25(5):565-72. PubMed ID: 6154661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of human natural cell-mediated cytotoxicity by interferon.
    Moore M; Potter MR
    Br J Cancer; 1980 Mar; 41(3):378-87. PubMed ID: 6155926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of lymphocytes from F 344 rats bearing intraocular tumor derived from human adenovirus 12-induced retinoblastoma-like cell line.
    Kobayashi M; Mukai N; Solish SP; Pomeroy ME
    Acta Pathol Jpn; 1984 Mar; 34(2):283-7. PubMed ID: 6331062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2.
    Cohen BL; Orn A; Gronvik KO; Gidlund M; Wigzell H; Murgita RA
    Scand J Immunol; 1986 Feb; 23(2):211-23. PubMed ID: 2419966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells.
    Grönberg A; Ferm M; Tsai L; Kiessling R
    Cell Immunol; 1989 Jan; 118(1):10-21. PubMed ID: 2463094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of lymphoma cells by autologous and allogeneic natural killer cells.
    Oshimi K; Oshimi Y; Yamada O; Mizoguchi H
    Blood; 1985 Mar; 65(3):638-43. PubMed ID: 2578838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
    Uchida A
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte toxicity in retinoblastoma.
    Rogers GL; Vo P
    South Med J; 1979 Sep; 72(9):1135-7. PubMed ID: 472839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.